CWP
RPRX icon

Concord Wealth Partners’s Royalty Pharma RPRX Stock Holding History

Concord Wealth Partners’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-40
Closed -$1.09K – 986
2023
Q3 		$1.09K Hold
40
– – ﹤0.01% 936
2023
Q2 		$1.23K Hold
40
– – ﹤0.01% 923
2023
Q1 		$1.44K Hold
40
– – ﹤0.01% 856
2022
Q4 		$1.58K Buy
+40
New +$1.67K ﹤0.01% 991
2022
Q3 		– Sell
-40
Closed -$2K – 928
2022
Q2 		$2K Hold
40
– – ﹤0.01% 1056
2022
Q1 		$2K Hold
40
– – ﹤0.01% 1130
2021
Q4 		$2K Hold
40
– – ﹤0.01% 1159
2021
Q3 		$1K Hold
40
– – ﹤0.01% 860
2021
Q2 		$2K Hold
40
– – ﹤0.01% 914
2021
Q1 		$2K Buy
+40
New +$1.9K ﹤0.01% 851

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return